Chemed Corporation officer and director Kevin J. McNamara filed a Form 144 notice of proposed sale of 2,000 shares of Chemed common stock, dated November 3, 2026, through Merrill Lynch on the NYSE.
Key Highlights
- Proposed sale: Kevin J. McNamara intends to sell 2,000 shares of Chemed Corporation common stock with an aggregate market value of $1,084,360.
- Approximate sale date: November 3, 2026, through Merrill Lynch, located at 5905 E Galbraith Road, Suite 7000, Cincinnati, OH 45236.
- Shares outstanding: According to the filing, 13,014,915 shares of common stock were outstanding at the time of the notice.
- Acquisition history: The shares to be sold were acquired via stock awards from Chemed Corporation on May 5, 2025 (1,018 shares), February 14, 2025 (679 shares), and May 2, 2023 (303 shares).
- Recent sales activity: McNamara sold 2,000 shares on each of three prior occasions in the past three months: August 21, 2026 (gross proceeds $1,082,324), September 17, 2026 (gross proceeds $1,002,789), and September 28, 2026 (gross proceeds $1,026,895).
- Relationship to issuer: McNamara is identified in the filing as an officer and director of Chemed Corporation.
McNamara's Proposed Sale and Acquisition Background at Chemed Corporation
According to the Form 144 notice filed with the U.S. Securities and Exchange Commission on November 3, 2026, Kevin J. McNamara, an officer and director of Chemed Corporation (NYSE:CHE), proposes to sell 2,000 shares of the company's common stock. The filing lists an aggregate market value of $1,084,360 for the proposed sale, with Merrill Lynch named as the executing broker.
The filing discloses that the shares intended for sale were acquired through stock awards granted by Chemed Corporation itself. Specifically, 1,018 shares were acquired on May 5, 2025, 679 shares on February 14, 2025, and 303 shares on May 2, 2023, with each acquisition characterized as a stock award with payment described as stock exercise. No cash consideration or installment payments are indicated in the filing for these acquisitions.
The filing also reports McNamara's sales during the three months preceding the notice. He sold 2,000 shares on August 21, 2026, generating gross proceeds of $1,082,324; another 2,000 shares on September 17, 2026, with gross proceeds of $1,002,789; and 2,000 shares on September 28, 2026, with gross proceeds of $1,026,895. The notice was signed by Marsha L. Conley on McNamara's behalf. Chemed Corporation's principal address is listed as 255 E 5th Street, Suite 2600, Cincinnati, Ohio 45202.
What Was Disclosed
The Form 144 notice discloses Kevin J. McNamara's proposed sale of 2,000 Chemed Corporation common shares with an aggregate market value of $1,084,360, along with the acquisition dates of those shares and three prior sales totaling 6,000 shares in the preceding three months.




Please wait processing your request...